Vertex Pharma upgraded at Canaccord Genuity after Q4 results
Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.
German TeamViewer posts mid-term targets after completing 1E acquisition
(Reuters) - German software developer TeamViewer posted on Wednesday mid-term revenue growth targets after it closed its ...